E. Klein

Outcome of breast cancer patients with low hormone receptor positivity: Analysis of a 15-year population-based cohort.

W. Weichert, C. Denkert, M. Kiechle, 2021, Annals of oncology : official journal of the European Society for Medical Oncology.

Radioiodine Treatment and Thyroid Hormone Suppression Therapy for Differentiated Thyroid Carcinoma: Adverse Effects Support the Trend toward Less Aggressive Treatment for Low-Risk Patients

T. Links, E. Klein, E. Hesselink, 2015, European Thyroid Journal.

Superficial bladder cancer: the role of interferon-alpha.

A. Belldegrun, U. Nseyo, T. Ratliff, 1998, The Journal of urology.

The impact of adjuvant nephrectomy on multimodality treatment of metastatic renal cell carcinoma.

A. Novick, R. Bukowski, D. Goldfarb, 1994, The Journal of urology.

Phase II trial of interleukin-2 and interferon-alpha in patients with renal cell carcinoma: clinical results and immunologic correlates of response.

T. Olencki, A. Novick, J. Finke, 1997, Journal of immunotherapy.

Renal masses simulating primary renal cell carcinoma in patients with advanced malignancies.

R. Bukowski, E. Klein, E. Klein, 1994, The Journal of urology.

1552O Chemotherapy-induced peripheral neuropathy (CIPN) prevention trial evaluating the efficacy of hand-cooling and compression in patients undergoing taxan-based (neo-)adjuvant chemotherapy for primary breast cancer: First results of the prospective, randomized POLAR trial

A. Schneeweiss, M. Weiler, F. Marmé, 2022, Annals of Oncology.

Plasma cell-free DNA (cfDNA) assays for early multi-cancer detection: The circulating cell-free genome atlas (CCGA) study.

E. Hubbell, A. Aravanis, J. Beausang, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Sunitinib in patients (pts) with unresectable primary renal cell carcinoma (RCC).

B. Lane, B. Rini, R. Dreicer, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.